Author

S. L. Briner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:C. elegans· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Ozdilek· 1 shared A. V. Paschall· 1 shared E. A. Gaylord· 1 shared F. Avci· 1 shared G. Chen· 1 shared H. L. Choy· 1 shared M. A. Brindley· 1 shared T. L. Doering· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Ozdilek

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Sac1 links phosphoinositide turnover to cryptococcal virulence

E. A. Gaylord, H. L. Choy, G. Chen, S. L. Briner, T. L. Doering

This study identifies Sac1 as a key factor in cryptococcal virulence by linking phosphoinositide turnover to host cell uptake and capsule production through genome-scale screening.

bioRxiv · Jan 18, 2024Microbiology

Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice

A. V. Paschall, A. Ozdilek, S. L. Briner, M. A. Brindley, F. Avci

This study shows that immunosuppressants reduce SARS-CoV-2 vaccine efficacy in mice, but temporarily stopping some drugs improves antibody responses.

bioRxiv · Sep 28, 2021Immunology